Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin - PubMed (original) (raw)
Comparative Study
. 2004 Jun 3;23(26):4594-602.
doi: 10.1038/sj.onc.1207602.
Affiliations
- PMID: 15077177
- DOI: 10.1038/sj.onc.1207602
Comparative Study
Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin
Bin Li et al. Oncogene. 2004.
Abstract
Amplification and mutation of the epidermal growth factor receptor (EGFR) are common features of malignant gliomas. The most frequent mutation seen in these tumors involves deletion of exon 2-7 resulting in a constitutively active form of the receptor (EGFRvIII, or deltaEGFR). Since EGFRvIII is found primarily in gliomas and has not been reported in sarcomas, we compared the effects of this altered receptor in immortalized primary astrocytes and fibroblasts. While EGFRvIII displayed ligand-independent autophosphorylation in both cell types, downstream signaling differed. While EGFRvIII increased the proliferative capacity of both astrocytes and fibroblasts consistent with activation of ERK in these cells, EGFRvIII activated AKT only in the immortalized astrocytes. EGFRvIII expression in astrocytes also led to increased radioresistance in that cell type. Furthermore, specific inhibition of phosphotidylinositol-3 kinase (PI-3K) with LY294002 reverted the radioresistant phenotype in the immortalized astrocytes. Thus, selective activation of PI-3K/AKT in astrocytes expressing EGFRvIII appears to be responsible for the observed increase in radioresistance. EGFRvIII's differential ability to activate the PI-3K downstream signal may explain why this mutant receptor is such a prominent lesion in malignant gliomas but less often seen in other tumor types, even those where EGFR signaling has a prominent role.
Similar articles
- Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y, Nagane M, Mishima K, Huang HJ, Furnari FB, Cavenee WK. Narita Y, et al. Cancer Res. 2002 Nov 15;62(22):6764-9. Cancer Res. 2002. PMID: 12438278 - Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B, Chang CM, Yuan M, McKenna WG, Shu HK. Li B, et al. Cancer Res. 2003 Nov 1;63(21):7443-50. Cancer Res. 2003. PMID: 14612544 - EGFRvIII-mediated radioresistance through a strong cytoprotective response.
Lammering G, Hewit TH, Valerie K, Contessa JN, Amorino GP, Dent P, Schmidt-Ullrich RK. Lammering G, et al. Oncogene. 2003 Aug 28;22(36):5545-53. doi: 10.1038/sj.onc.1206788. Oncogene. 2003. PMID: 12944901 - Ligand-Independent EGFR Signaling.
Guo G, Gong K, Wohlfeld B, Hatanpaa KJ, Zhao D, Habib AA. Guo G, et al. Cancer Res. 2015 Sep 1;75(17):3436-41. doi: 10.1158/0008-5472.CAN-15-0989. Epub 2015 Aug 17. Cancer Res. 2015. PMID: 26282175 Free PMC article. Review. - Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.
Hatanpaa KJ, Burma S, Zhao D, Habib AA. Hatanpaa KJ, et al. Neoplasia. 2010 Sep;12(9):675-84. doi: 10.1593/neo.10688. Neoplasia. 2010. PMID: 20824044 Free PMC article. Review.
Cited by
- Akt: a double-edged sword in cell proliferation and genome stability.
Xu N, Lao Y, Zhang Y, Gillespie DA. Xu N, et al. J Oncol. 2012;2012:951724. doi: 10.1155/2012/951724. Epub 2012 Mar 15. J Oncol. 2012. PMID: 22481935 Free PMC article. - Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.
Pines G, Köstler WJ, Yarden Y. Pines G, et al. FEBS Lett. 2010 Jun 18;584(12):2699-706. doi: 10.1016/j.febslet.2010.04.019. Epub 2010 Apr 11. FEBS Lett. 2010. PMID: 20388509 Free PMC article. Review. - The radiobiological effects of He, C and Ne ions as a function of LET on various glioblastoma cell lines.
Chew MT, Bradley DA, Suzuki M, Matsufuji N, Murakami T, Jones B, Nisbet A. Chew MT, et al. J Radiat Res. 2019 Mar 1;60(2):178-188. doi: 10.1093/jrr/rry099. J Radiat Res. 2019. PMID: 30624699 Free PMC article. - EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment.
Keller S, Schmidt MHH. Keller S, et al. Int J Mol Sci. 2017 Jun 18;18(6):1295. doi: 10.3390/ijms18061295. Int J Mol Sci. 2017. PMID: 28629170 Free PMC article. Review. - Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
Bouras A, Kaluzova M, Hadjipanayis CG. Bouras A, et al. J Neurooncol. 2015 Aug;124(1):13-22. doi: 10.1007/s11060-015-1807-0. Epub 2015 May 17. J Neurooncol. 2015. PMID: 25981803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous